INTESTINAL EFFLUX SYSTEMS such as P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP), and breast cancer resistance protein (BCRP) act as guardians protecting the organism against potentially harmful xenobiotics (36). These members of the ATP-binding cassette transporter superfamily (i.e., ABC transporters) reduce solute transfer across the apical membrane of enterocytes by actively extruding substrates in a concentration-and energy-dependent process, thus limiting oral absorption (4) . Clinical reports have underlined the importance of changes in functional activity of intestinal efflux systems with respect to the bioavailability of therapeutic agents (27) . Consequently, molecular mechanisms of drug-drug and food-drug interactions that alter intestinal efflux activities are currently investigated (16) .
Pharmacotherapy of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), requires administration of immunosuppressive drugs exhibiting significant substrate activities for intestinal efflux systems. Remarkably, up to 40% of patients with severely active IBD fail to respond to continuous high-dose intravenous cyclosporin A (CysA), whereas the observed poor efficacy of oral CysA appears to result from high variability in enteral absorption (38) . Because IBD patients failing drug therapy and undergoing corrective surgery also exhibit constitutively elevated P-gp expression in enterocytes and peripheral blood lymphocytes (14, 20, 44) , it was hypothesized that pathophysiological mediators involved in the etiology of IBD modulate functional activity of intestinal efflux systems. In general, CD and UC are associated with an immune imbalance manifested by a dramatic luminal overproduction of proinflammatory cytokines, mainly TNF-␣, IL-1␤, and IFN-␥ (7). These cytokines activate transcription factors such as NF-B that can increase expression of target genes, including inducible nitric oxide (NO) synthase (iNOS). Subsequent production of NO has been reported to disrupt paracellular barrier properties of the intestinal mucosa facilitating bacterial passage across the epithelial barrier, which aggravates local inflammation (25, 40) .
Functional regulation of ABC transporters by proinflammatory cytokines has been demonstrated in various in vitro and in vivo studies. Nevertheless, the results are ambiguous, and the effects appear to be species-and cell type-specific (30) . In mice, IFN-␥ decreased P-gp expression in the liver and small intestine but not in the brain (23) . In contrast, incubation of human macrophages with this cytokine stimulated upregulation of the ABCB1 gene encoding for P-gp (35) , whereas its functional activity decreased in HT116 colon carcinoma cells after cytokine stimulation (41) . Recent reports (3, 6) indicated that ABCB1 mRNA and P-gp protein levels in differentiated, small intestine-like Caco-2 cells were increased in response to IFN-␥. Apparently, those molecular changes did not augment functional activity of this efflux system. In contrast, information regarding effects of cytokines on other members of the ABC transporter superfamily is more limited. It was shown that inflammatory stimuli such as endotoxin, TNF-␣, and IL-1␤ downregulate MRP2 (18) . Nevertheless, the effect of IFN-␥ on intestinal MRP2 expression and function remains unknown.
In the present study, we investigated whether IFN-␥ alters functional activity of intestinal membrane efflux systems using Caco-2 cells that exhibit a predominantly colonic phenotype (2, 13) . Furthermore, the role of iNOS and NO, key mediators in the pathogenesis of IBD, was assessed in modulating intestinal P-gp activity after IFN-␥ stimulus.
MATERIALS AND METHODS
Cell culture. Caco-2 cells originally obtained at passage 18 from ATCC (Rockville, MD) were routinely maintained at 37°C in a controlled atmosphere of 5% CO 2-90% relative humidity using DMEM supplemented with 1% L-glutamine, 100 IU/ml penicillin, 100 g/ml streptomycin, 1% nonessential amino acids (Mediatech, Herndon, VA), and 10% heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA). When ϳ80% confluent, cells were detached from 75-cm 2 flasks using PBS/EDTA (0.02%) and trypsin EDTA (0.025/ 0.05%) in PBS. Caco-2 cells between passages 25 and 35 were used in this study.
Cellular uptake studies. For uptake studies, cells were seeded in 12-well plastic plates (Costar, Cambridge, MA) at a density of 2.2 ϫ 10 5 cells/well. Medium was changed every other day, and cells were used 12 days postseeding where a significant fraction of the cell population still exhibits a colonic phenotype (2, 13) . After cell monolayers were washed three times with HBSS, pH 7.4, uptake was initiated by adding 1 ml HBSS that contained a trace amount of the radioactive solute ([ 3 H]CysA, specific activity ϭ 8 Ci/mmol; Moravek Biochemicals, Brea, CA or [
3 H]MTX, specific activity ϭ 23 Ci/mmol; Amersham Life Sciences, Piscataway, NJ). Uptake studies were terminated after 2 h by washing with ice-cold HBSS. Cell monolayers were dissolved in 1 N NaOH, the solution was neutralized with HCl, and intracellular radioactivity was quantified by liquid scintillation counting. Substrate specificity for selected efflux systems was delineated by inclusion of 2 M of the P-gp inhibitor GF-120918 (generous gift from Dr. Joseph Polli, GlaxoSmithKline, Collegeville, PA) and 50 M of the MRP2 inhibitor MK-571 (LKT Laboratories, St. Paul, MN), respectively. Total protein content was determined by using the Bradford assay (Bio-Rad Laboratories, Hercules, CA). To assess the effect of IFN-␥ on intracellular solute uptake, Caco-2 monolayers were preincubated through 48 h with this cytokine using medium supplemented with 1-100 ng/ml of recombinant human IFN-␥ (Leinco Chemicals, St. Louis, MO). Alternatively, Caco-2 cell monolayers were pretreated with 10 ng/ml of IFN-␥ in the presence and absence of 1 mM L-N 6 -(1-iminoethyl)lysine (L-NIL) and 100 M aminoguanidine, respectively, or incubated for 6 h with 0.1-5 mM of S-nitroso-N-acetylpenicillamine (SNAP).
P-gp immunoblot analysis. Frozen control and cytokine-treated Caco-2 cells (ϳ3.5 ϫ 10 7 ) were lysed in sample buffer (Invitrogen, Carlsbad, CA). Total protein in cell lysates was determined by using the Bradford assay. After boiling samples for 5 min, 20 g equivalents of total protein were subjected to 7.5% SDS-PAGE. Samples were then transferred to a polyvinylidene difluoride membrane (Immobilon-P, Millipore, Bedford, MA), blocked in 5% nonfat dry milk prepared in TBS (0.1%)/Tween 20 (TBST), and probed overnight with a monoclonal anti-P-gp antibody (F4, 1:2,000; Sigma, St. Louis, MO). Membranes were washed three times with TBST and incubated with peroxidase-conjugated goat anti-mouse secondary antibody (1: 10,000). After development with Western Blot Luminescence Reagent (Pierce Biotechnology, Rockford, IL), visible bands were quantified densitometrically using ImageQuant. Arbitrary densitometric units were normalized to vehicle-treated controls, and the means Ϯ SD of at least three replicates is reported in addition to the scan of one representative immunoblot.
NO production. As an indicator of NOS activity, nitrate/nitrite production was colorimetrically measured in cell supernatant using the Griess reaction (46) . Briefly, nitrate in the extracellular medium was reduced to nitrite by incubation for 3 h with nitrate reductase (670 mU/ml) and NADPH (160 mM) at room temperature. One hundred microliters of the Griess reagent (0.1% naphthalethylenediamine dihydrochloride in water and 1% sulfanilamide in 5% concentrated phosphoric acid; volume 1:1) was added to 100-l samples, and optical density was measured at 550 nm using a Spectramax 250 microplate reader (Molecular Devices, Menlo Park, CA). Total nitrate and nitrite concentrations were calculated by using standard curves prepared with sodium nitrate and sodium nitrite, respectively.
NF-B EMSA. Caco-2 cells (ϳ10 7 ) treated with 10 ng/ml of IFN-␥ or vehicle (control) through 48 h were harvested by scraping and homogenized in 1.5 ml of a homogenizing buffer using a polytron. Homogenizing buffer was composed of (in mM): 10 Tris ⅐ HCl, pH 7.4, 1 EGTA, 2 EDTA, 5 NaN 3, 10 ␤-mercaptoethanol, 0.2 PMSF, 50 NaF, and 1 sodium orthovanadate, plus 0.32 M sucrose, 20 M leupeptin, 0.15 M pepstatin A, and 0.4 nM microcystin. After low-speed centrifugation (1,000 g, 10 min), the pellet was solubilized in a Triton buffer (in mM: 150 NaCl, 10 Tris ⅐ HCl, pH 7.4, 1 EGTA, 1 EDTA, 0.2 sodium orthovanadate, and 0.2 PMSF, plus 1% Triton X-100 and 20 M leupeptin A). Nuclear debris was removed by centrifugation at 15,000 g for 30 min (4°C), nuclear extracts collected in the supernatant, and protein concentration was determined by using the Bradford assay. A 44 bp NF-B consensus oligonucleotide (5Ј-GAT CGA GGG GAC TTT CCC TAG C-3Ј) was 32 P end labeled using T4 polynucleotide kinase. Nuclear proteins (20 g) were incubated for 30 min at room temperature with the labeled oligonucleotide in an incubation buffer consisting of 1 M MgCl 2, 500 mM HEPES (pH 7.5), 5 M NaCl, 20% glycerol, 5 M EDTA, 100 mM DTT, 0.2 mM PMSF, and 25 g/ml leupeptin. DNA-protein complexes were resolved by electrophoresis using nondenaturing 5% polyacrylamide gels. Sample loading was adjusted to equal protein concentration. The dried gel was exposed to X-ray film for 5-6 h. Specific protein-DNA interactions were evaluated by addition of a 50-and 100-fold molar excess of unlabeled oligonucleotide as a competitive inhibitor. Nuclear extracts from Caco-2 cells incubated for 2 h with 10 ng/ml of IL-6 served as positive controls (43) . Similarly, DNA-protein complexes were resolved, from nuclear extracts obtained from Caco-2 cells that were treated during 48 h with 10 ng/ml IFN-␥ in the presence and absence of 1 mM L-NIL, 100 M aminoguanidine, and 1 mM SNAP during 2 h, respectively.
Statistical analysis. Experiments were performed at least in triplicate, and the results are expressed as means Ϯ SD. Significant statistical differences between control and experimental groups were evaluated by using one-way ANOVA followed by Newman-Keuls posttest at the significance level of P Ͻ 0.05.
RESULTS

IFN-␥ alters intracellular uptake of substrates for intestinal efflux systems.
Initially, the relationship between extracellular IFN-␥ concentrations, incubation time, and functional activity of intestinal efflux systems was determined by quantifying cellular uptake of the P-gp substrate CysA and the MRP2 substrate methotrexate (MTX) (Fig. 1) . Substrate specificity for these two membrane efflux systems was verified by using the selective P-gp inhibitor GF-120918 and MRP2 inhibitor MK-571, respectively (data not shown). Incubation of Caco-2 cell monolayers with 1 ng/ml of IFN-␥ during 48 h did not alter uptake of either substrate for these efflux systems. However, significant changes in intracellular CysA levels were observed after a 12-h preincubation with 100 ng/ml and a 24-h treatment with 10 ng/ml of IFN-␥, respectively, suggesting increased P-gp efflux activity (Fig. 1A) . A maximum of ϳ35% decrease in cellular uptake of CysA was measured after 48 h with 10 ng/ml of IFN-␥. This was not significantly different from changes in efflux activity induced after the same time by 100 ng/ml of IFN-␥ (P Ͼ 0.05). In contrast, intracellular uptake of MTX was not affected by this cytokine, implying a predominant effect of IFN-␥ on P-gp regulation in this cell culture model (Fig. 1B) . Because functional activity of both P-gp and MRP2 are critically dependent on the availability of ATP (1), we conclude that IFN-␥ treatments did not negatively impact the cellular energy status, which is consistent with results from 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) viability studies (data not shown).
IFN-␥ increases intestinal P-gp expression.
To assess whether changes in intracellular CysA measured in IFN-␥-stimulated cells were related to altered P-gp regulation, we determined protein expression of this efflux system using immunoblots (Fig. 2) . Densitometric analysis revealed that preincubation of Caco-2 cells with IFN-␥ (Ն10 ng/ml) increased P-gp expression in a concentration-and time-dependent manner. Consistently, most dramatic increases in the expression of this efflux system (Ն1.5-fold) were measured after 48 h with 10 -100 ng/ml of IFN-␥. These results are in agreement with the functional data shown in Fig. 1A and suggest that IFN-␥ decreases intracellular uptake of CysA through mechanisms that enhance P-gp expression in the apical membrane of Caco-2 cells.
IFN-␥ activation of iNOS and intestinal P-gp.
The clinical pathology of IBD is intimately linked to cytokine-induced upregulation of intestinal iNOS activity with increased production of NO (40) . To investigate whether changes in iNOS protein activity after IFN-␥ stimulus affect P-gp efflux function in Caco-2 cells, extracellular nitrate/nitrite concentrations were determined as an indirect measure of cytokine-induced, iNOSmediated intracellular NO production. After a 12-h incubation with 1-100 ng/ml of IFN-␥, cell supernatant nitrate/nitrite increased by at least 95% (Table 1) . Production of this reactive oxygen intermediate continued through 48 h with a maximum ninefold increase compared with control levels in cells exposed to 100 ng/ml of this cytokine. Addition of the irreversible iNOS inhibitor L-NIL (1 mM) significantly reduced IFN-␥-stimulated NO production (P Ͻ 0.05). These results suggest that IFN-␥ stimulates iNOS activity in Caco-2 cells leading to increased NO production in a time-and concentration-dependent manner. To extend these observations, which are consistent with earlier reports (8, 9), we measured intestinal efflux activity of P-gp in Caco-2 cells treated with 10 ng/ml of IFN-␥. This cytokine concentration was selected because it corresponds to the pathophysiological concentration range reported in the intestinal lumen of IBD patients (32) . Moreover, exposure of Caco-2 cells to a 10-fold greater IFN-␥ concentration (i.e., 100 ng/ml) increased NO production only moderately (Table 1) . Compared with control cells, intracellular CysA uptake was significantly decreased after IFN-␥ stimulus (Fig.  3A) , with the most dramatic effect measured after 48 h (5.15 Ϯ 0.23 nmol/mg protein vs. 3.13 Ϯ 0.18 nmol/mg protein, P Ͻ 0.05). Inclusion of the iNOS inhibitor L-NIL completely abolished the cytokine-induced increase in P-gp function, which is in agreement with previously observed effects on NO production (Table 1) . Consistent results were obtained by using the chemically dissimilar iNOS inhibitor aminoguanidine (data not shown). Quantitative evaluation of immunoreactive protein revealed a 70% increase in P-gp expression after a 48-h incubation with 10 ng/ml of IFN-␥. Consistent with our functional activity data, expression of this efflux system was not significantly different from control when L-NIL was included together with IFN-␥ (Fig. 3C) . These results suggest that NO is required for IFN-␥-mediated effects on intestinal P-gp and may act as a biochemical regulator of ABCB1 gene transcription.
NO donor increases intestinal P-gp activity. Because pharmacological inhibition of iNOS dramatically reduced the effect of IFN-␥ on P-gp expression and functional activity, experiments were designed to identify the role of NO as a mediator of cytokine-induced regulation of this intestinal efflux system. Caco-2 cell monolayers were incubated with 0.1-5 mM of the NO donor SNAP, and NO production was measured over 6 h using the Griess reaction (Table 2 ). Cell viability throughout this time period was Ͼ95% determined by the MTT assay (data not shown). Supernatant nitrate/nitrite concentrations increased in parallel to greater extracellular SNAP concentrations. At maximum, the cells incubated with 5 mM of SNAP were exposed to a 13-fold increased NO level compared with controls (P Ͻ 0.05). Interestingly, total nitrite concentrations after a 6-h incubation with 1 mM of SNAP were comparable to the levels measured after a 48-h exposure of Caco-2 cells to 10 ng/ml of IFN-␥, which represents a pathophysiologically reported cytokine concentration in the gastrointestinal lumen of IBD patients (32) .
Effect of SNAP on intestinal efflux activity is shown in Fig.  4A . At all concentrations studied, intracellular accumulation of CysA decreased by at least 30% (P Ͻ 0.05). This indicates that a threefold increase in nitrate/nitrite concentrations compared Results are expressed as means Ϯ SD; n ϭ 6. Total nitrate/nitrite in cell supernatants in micrometers was determined using the Griess reaction. *Statistical significance between control and treatment groups was determined using one-way ANOVA followed by the Newman-Keuls test at the significance level of P Ͻ 0.05. L-NIL, L-N 6 -(1-iminoethyl) lysine. A: intracellular accumulation of CysA was determined and normalized to vehicle-treated controls. P-gp protein expression after a 48-h exposure to the cytokine was determined by using immunoblots. B and C: visible bands were quantified densitometrically using ImageQuant and normalized to vehicle-treated controls. All experiments were performed in triplicate. Data are presented as means Ϯ SD. *Statistical significance of results was tested by using one-way ANOVA followed by the Newman-Keuls test (P Ͻ 0.05).
with controls significantly enhanced the functional activity of intestinal P-gp. In contrast, changes in immunoreactive P-gp protein were only measured after exposure of cells to SNAP at concentrations of Ն1 mM. These results strongly support a role for NO as a biochemical mediator in the IFN-␥-activated signaling cascade that alters functional activity of the P-gp efflux system.
IFN-␥ increases DNA binding of transcription factor NF-B.
The clinical course of intestinal inflammation is paralleled by increased production of proinflammatory cytokines and subsequent activation of signaling molecules, including NF-B (37). The same transcription factor is implicated in elevating expression and functional activity of P-gp in drug-resistant tumor cells and renal epithelium (5, 26, 42) . DNA binding activity of NF-B in nuclear extracts from Caco-2 cells incubated with 10 ng/ml of IFN-␥ was increased as early as 15 min posttreatment and gradually decreased after 60 min (Fig. 5A) . Specificity of the labeled oligonucleotide consensus sequence was validated by using nuclear extracts of cells incubated with 10 ng/ml of IL-6 that activates NF-B binding in Caco-2 cells (43) and addition of 50-and 100-fold excess of the unlabeled oligonucleotide probe (Fig. 5A, lanes 5 and 6) . Interestingly, enhanced DNA binding activity of this transcription factor in nuclear extracts of IFN-␥-stimulated cells appears to undergo time-dependent changes and shows increased binding again at 24 h (Fig. 5B, lane 2) . Coincubation with L-NIL dramatically reduced NF-B binding to a level similar as in nuclear extracts of control cells (Fig. 5B, lane 3) . L-NIL alone, however, did not alter NF-B binding (Fig. 5B, lanes 4 and 5) . Consistent results were obtained by using the chemically dissimilar iNOS inhibitor aminoguanidine (data not shown). These observations suggest that cytokine-induced changes in intracellular NO levels of Caco-2 cells impact DNA binding of NF-B, which, consequently, may affect transcription of target genes, including the P-gp encoding ABCB1. Additional support for this conclusion was obtained by evaluating the NF-B binding pattern in cells that were treated with 1 mM of SNAP (Fig. 5C ). Within 15 min of exposure to this chemical NO donor DNA binding of the transcription factor was activated and remained strong until 90 min. These results provide the first evidence that NO may contribute to IFN-␥-dependent regulation of intestinal P-gp by modulating nuclear binding activity of NF-B.
DISCUSSION
Biochemical and molecular pathways that alter expression of membrane efflux systems in enterocytes of IBD patients are largely unknown. We have demonstrated that exposure of human, colon-like, intestinal Caco-2 cells to apical IFN-␥ concentrations corresponding to cytokine levels measured in the gastrointestinal lumen of IBD patients (32) significantly decreased intracellular accumulation of CysA but not MTX. In accordance with established substrate specificity, reduced cellular uptake of CysA suggested that this cytokine primarily alters functional activity of P-gp. In addition, it may modulate activity of other members of the ABC transporter superfamily, including MRP2 and BCRP (12, 45) , although less effectively. Earlier, significant increases in ABCB1 mRNA and P-gp protein levels were reported in differentiated, small intestine-like Caco-2 cells after incubation with 10 ng/ml of IFN-␥ (3, 6). Apparently, those molecular changes did not augment func- Fig. 4 . NO modulates intestinal P-gp expression and function. Caco-2 cells grown in 12-well plastic plates for 12 days were treated for 6 h with 0.1-5 mM of SNAP. Intracellular accumulation of CysA (A) and P-gp protein expression using immunoblots followed by densitometric analysis were normalized to vehicle-treated controls (B and C). All experiments were performed in triplicate. Data are presented as means Ϯ SD. *Statistical significance of results was tested by using one-way ANOVA followed by the Newman-Keuls test (P Ͻ 0.05). Results are expressed as means Ϯ SD; n ϭ 6. Total nitrate/nitrite in micrometers in cell supernatants was determined using the Griess reaction. Caco-2 monolayers were incubated with 0.1-5 mM of SNAP for 6 h. *Statistical significance between control and treatment groups was determined using one-way ANOVA followed by the Newman-Keuls test at the significance level of P Ͻ 0.05. SNAP, S-nitroso-N-acetylpenicillamine.
tional activity of this efflux system as determined by transepithelial transport of rhodamine 123 from the basolateral to the apical direction. In our experiments, P-gp activity was quantitatively assessed by using cellular uptake of the P-gp substrate CysA. As a consequence, reduced intracellular accumulation of this solute directly correlates with increased activity of this efflux system expressed in the apical membrane of Caco-2 cells. In contrast to bidirectional transport studies, this experimental approach eliminates confounding cytokine effects on tight-junction barrier properties of cell monolayers, which may increase paracellular solute flux (29, 47) . From the results presented in this study, we concluded that increased P-gp protein levels and enhanced efflux activity most likely reflect molecular consequences of greater P-gp protein synthesis, which is in agreement with the earlier reported increase in IFN-␥-induced ABCB1 gene transcription (3, 6) . Nevertheless, reduced proteosomal P-gp degradation and/or altered intracellular sorting of this efflux system cannot be excluded.
IFN-␥ has been implicated in causing a global phenotypic switch in intestinal epithelial function during inflammation (10, 34) . Some of these cytokine-induced changes contribute to progression of intestinal inflammation, whereas other effects are more immunosuppressive. This ambivalent role of IFN-␥ in inflammation is cell type specific and appears to result from selective regulation of various target genes after activation of a complex interplay of cell signal transduction pathways (31) . In IBD patients, iNOS expression and enzymatic activity dramatically increase in response to IFN-␥ and other proinflammatory cytokines. Consequently, they are clinically employed as biochemical markers of disease progression (25) . Binding of IFN-␥ to its membrane receptor classically activates the JAK/ STAT pathway (11) . Generally, it is accepted that this signaling mechanism participates in IFN-␥-mediated activation of intestinal iNOS. However, other pathways may also contribute to the regulation of this important response gene, particularly activation of NF-B (8, 15, 17) . Results from the present study support activation of this transcription factor through IFN-␥ signaling. Within 15 min of the IFN-␥ stimulus, nuclear binding of NF-B dramatically increased and decreased around 2 h but reappeared strongly 24 h posttreatment. Interestingly, binding of this transcription factor to the radiolabeled consensus oligonucleotide probe also increased after exposure of the cells to the NO donor SNAP. This implies that NO, the biochemical end product of the IFN-␥-stimulated intestinal iNOS gene, significantly contributes to altered nuclear binding of this transcription factor and, consequently, may positively regulate its own production. Future studies will have to address in more detail the contribution of NO and associated reactive nitrogen species such as peroxynitrite in molecular regulatory mechanisms underlying this observation.
Physiologically, intestinal membrane efflux systems are proposed to protect the organism against uncontrolled entry of potentially harmful compounds (24) . Elevated P-gp expression combined with increased efflux activity in inflamed intestinal tissue therefore could represent a response of the enterocyte to a hostile microenvironment in an attempt to sustain vital gastrointestinal barrier function. The contribution of ABC transporters in protecting the organism from gastrointestinal proinflammatory stimuli was recently demonstrated in vivo (33) . Here, P-gp knockout (mdr1a Ϫ/Ϫ ) mice maintained in a pathogen-free environment spontaneously developed UC because antigen efflux from enterocytes was dramatically reduced. Consistent with these studies, it is hypothesized that reduced P-gp expression in the duodenum as a result of C3435T single nucleotide polymorphism in exon 26 of the A: DNA-protein complexes through 120 min were resolved by PAGE, and nucleoprotein complexes were detected by autoradiography. Competition studies using a 50-and 100-fold molar excess of unlabeled, NF-B-specific oligonucleotide probe were performed at 30 min (lanes 5 and 6). Nuclear extract from IL-6-treated cells (10 ng/ml for 120 min) served as a positive control (lane 9). B: results from similar experiments performed in the presence and absence of L-NIL (1 mM) using nuclear extracts 24 and 48 h posttreatment, respectively. Finally, binding activity profile of the radiolabeled, double-stranded NF-B oligonucleotide probe through 120 min was determined by using nuclear extracts from Caco-2 cells incubated with 1 mM of SNAP (C). Individual panels depict representative EMSA results that were confirmed in at least 2 additional experiments. Sample loading was adjusted to equal protein concentration.
ABCB1 gene may predispose human subjects to development of UC (39) .
With the use of the Caco-2 cell culture model, we demonstrated that IFN-␥-induced changes in P-gp expression and functional activity critically depend on the presence of NO. Inhibition of iNOS completely abrogated cytokine-induced effects on this efflux system. NO regulates a wide range of physiological responses and has traditionally been associated as an effector of fast-acting signaling cascades that rapidly subside after the disappearance of the original stimulus [e.g., Ca 2ϩ influx (21)]. In addition, NO can stimulate signaling pathways that regulate gene expression and, consequently, elicit long-lasting changes in the cell. Recent microarray data in fibroblasts identified three distinct kinetic waves of gene activation by NO (19) . The authors of this study also applied pharmacological and genetic approaches to determine the signaling pathways used by NO to regulate gene expression. Specific groups of genes were identified that require the activity of phosphatidylinositol 3-kinase, protein kinase C, or NF-B. Activation of some genes, however, was sensitive to more than one inhibitor, suggesting the possibility of cross talk among various pathways in transducing the NO signal to the transcriptional machinery. In our study, incubation of Caco-2 cells with SNAP dramatically changed nuclear binding of NF-B. The susceptibility of this Cys-dependent transcription factor to nitrosylation and/or oxidation and the consequences arising for transcriptional reprogramming have been evaluated in various cell systems (22) . Whether NO may also affect JAK/STAT-mediated signaling events deserves further investigations.
Recently, NF-B was reported to contribute to transcriptional regulation of the ABCB1 gene (5, 26, 42) . The dramatic effects of SNAP-inducing activation of DNA binding of NF-B, which augmented P-gp activity and protein expression to a similar extent as IFN-␥, suggest that the interplay between NO and events upstream of nuclear NF-B binding control transcription and/or translation of this efflux system in colon-like enterocytes. However, NO could also alter intestinal efflux activity by modulating directly or indirectly intracellular protein sorting, ATPase activity, and/or protein phosphorylation status. Consequently, additional studies will be required to unveil the molecular mechanism underlying IFN-␥-induced upregulation of intestinal P-gp activity.
In conclusion, results presented in this study demonstrate that IFN-␥ increases protein expression and functional activity of intestinal P-gp in the human, colon-like, Caco-2 cell line in a time-and dose-dependent manner. Furthermore, our data suggest that cytokine-induced release of NO alters DNA binding of NF-B, which may enhance transcription of the ABCB1 gene encoding for this efflux system.
